GAS5 and colorectal cancer: Subsequently, gas5 was identified as a tumor suppressor, and prognosis marker in renal cell carcinoma, cervical cancer, malignant pleural mesothelioma, gastric cancer, colorectal cancer, endometrial cancer, and breast cancer [11, 21–29].